OHT Treatment criteria First Choice Treatment Dr. Jordi Loscos Arenas Hospital Universitari Germans Trias i Pujol, Barcelona.

Slides:

Advertisements

Similar presentations

Philosophies in Glaucoma

Advertisements

V Glaucoma Implementing NICE guidance 2009 NICE clinical guideline 85.

Topical glaucoma medication with a teal cap? Prostaglandin analogues – Xalatan® (latanoprost) 0.005% qd – Travatan®(travoprost) 0.004% qd – Lumigan® (bimatoprost)

Keratoconus – Genes and Risk Factors Tuesday 11 th November 2014 A/Professor Paul Baird Ocular Genetics Unit TRANSLATIONAL GENOMICS.

Paras Guide to Glaucoma

Biomechanical Properties of the Cornea in Normal- Tension Glaucoma Authors: Leonidas Traipe Ines Cayuqueo Fabiola Cerfogli Claudia Goya Allister Gibbons.

Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.

Clinical Guidance and Monitoring for Change Cecilia Fenerty MD FRCOphth.

Providing the full range of Local Enhanced Services: The case of Manchester Karen O’Brien Associate Director Primary Care Commissioning.

Comparison between Dynamic contour tonometry, Goldmann applanation tonometry and Ehlers-corrected Goldmann applanation tonometry in eyes after Laser In.

SAMIR AL-MANSOURI, MD. e.g. - cataract - glaucoma - macular degeneration - diabetic retinopathy Chronic = slowly progressive visual loss Major causes:

PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA

In the name of god Target IOP S.M.Shahshahan M.D Feb 2010.

Phacoemulsification with Goniosynechialysis in the Management of Refractory Acute Angle-closure Glaucoma Ghasem Fakhraie*, MD, Mahmoud Jabbarvand, MD,

SEI IOP and its correlations in a population based study in Central India. The Central India Eye and Medical Study. Krishna Bhojwani, Vinay Nangia, Jost.

The Diabetic Retinopathy Clinical Research Network Repeated Intravitreous Ranibizumab Injections for DME and Risk of Sustained IOP Elevation or Need for.

4/19/2017 Managing Patients With Ocular Hypertension Results From The Ocular Hypertension Treatment Study (OHTS) The American Glaucoma Society Michael.

New Glaucoma implants Uveoscleral implant : Esnoper Clip

OPEN ANGLE GLAUCOMA Frank J. Weinstock, MD, FACS Professor of Ophthalmology- NEOUCOM Canton, Ohio USA.

November 2006 Prediction Model Template from OHTS-EGPS Pooled Analyses Today’s version is November 14.

So-Hyang Chung, MD, PhD, Choun-Ki Joo, MD, PhD Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul,

The Ocular Hypertension Treatment Study (OHTS) Supported by the National Eye Institute, National Center on Minority Health and Health Disparities, Research.

A Prospective Trial Comparing Scleral Pneumotonometry to Goldmann Applanation Tonometry Sara Duke, MD, Usiwoma Abugo, BS, Shuchi Patel MD Loyola University.

 GLAUCOMA.  BY GROUPS 3 1. Siti Hadijah ( ) 2. I Putu Adi Styawan ( ) 3. Jaka Primadhana. R ( ) 4. Komang Ayu Pradnya Antari ( )

Will my Glaucoma patient lose vision ?

Glaucoma in United States Veterans: An Overlooked Group? Priyanka Kamath, MS; Zohra Prasla, BBA; Matthew Harrison, BS; Karanjit Kooner, MD Dallas Veterans.

TRANSPALPEBRAL TONOMETER APPLICATION DURING INTRAOCULAR PRESSURE EVALUATION IN THE PATIENTS WITH REFRACTION ANOMALY BEFORE AND AFTER KERATOPHOTOREFRACTIVE.

RANDOMIZED CLINICAL TRIALS IN GLAUCOMA- WHAT DO THEY TELL US? Dr Jyoti Shetty B.W.Lions superspeciality eye hospital.

Hayashi Eye Hospital, Fukuoka, Japan

TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?

Universita’ di Catania, Italia Clinica Oculistica Dir.: Prof. A. Reibaldi Purpose: To evaluate the efficacy and safety of Pneumotrabeculoplasty (PNT) in.

Retinal nerve fiber layer thickness change in patients with wet AMD treated with ranibizumab, short term results Advantages: To determine the effect of.

Adult Medical-Surgical Nursing Neurology Module: Glaucoma.

Effect of Corneal Thickness on Selective Laser Trabeculoplasty to Decrease Intraocular Pressure as Primary or Secondary Treatment of Glaucoma ASCRS 2010.

Descemet Stripping Automated Endothelial Keratoplasty in patients with Toxic anterior segment syndrome induced endothelial failure First and Presenting.

Mohamed Abdelzaher M.Sc. FOURTH YEAR BRAIN STORMING.

Combined cataract surgery and endoscopic cyclophotocoagulation in patients with glaucoma without prior incisional glaucoma surgery Matthew P. Traynor,

Alexander J. Brucker, M.D. Protocol Chair

E-Poster Rio de Janeiro Corneal Tomography and Biomechanics Study Group The study of the correlations of the optic disc size with Cornal Geometry and Biomechanical.

The effect of corneal edema on intraocular pressure measurements after phacoemulsification surgery Ilker Eser M.D. 1 Arzu Taskiran-Comez M.D. 1 Baris Komur.

بسم اللة الرحمن الرحيم. Limbal relaxing incisions versus penetrating limbal relaxing incisions for the management of astigmatism in cataract surgery Sara.

Sponsored by the National Eye Institute,

Visual and IOP Outcomes after PRK in Pigment Dispersion Syndrome [Poster Number: P190] Kraig S. Bower, Denise A. Sediq, Charles D. Coe, Keith Wroblewski,

Posner-Schlossman Syndrome Bianka Sobolewska, MD Manfred Zierhut, MD Centre of Ophthalmology University of Tuebingen, Germany.

Rate of Visual Field Progression in Eyes With Optic Disc Hemorrhages in the Ocular Hypertension Treatment Study De Moraes CG, Demirel S, Gardiner SK, et.

The Ocular Hypertension Treatment Study Group (OHTS)

HASAN MOHIDAT MD VITREORETINAL DISEASES AND SURGERY, JUST INTRODUCTION TO EYE DISEASES.

PRIMARY OPEN ANGLE GLAUCOMA PROF.DR.ÖZCAN OCAKOĞLU.

Glaucoma studies, IOP and treatment rationale W. H. Morgan RPH, LEI and PMH.

Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.

PROTECTING CELLS IN THE EYE AT RISK OF DAMGE FROM GLAUCOMA

Ophthalmology – Raised IOP Referrals (Adults only)

Target IOP Update Mohamed Yasser Sayed Saif Beni Suef University

Characteristics of Primary Angle-Closure Glaucoma Patients with Normal Intraocular Pressure at the First Visit Won Hyuk Oh1, Bum Gi Kim1, Joo Hwa Lee2.

Safety of medication reduction for Primary Angle Closure (PAC) –

Glaucoma Suspect - Shields Textbook of Glaucoma, 6th edition - 녹내장 개정5판, 한국녹내장학회 부천성모병원 안과 Ap.홍승우/R3 이국.

Review of Glaucoma Suspect

Early Intraocular Pressure Rise After Phacoemulsification In Non-Glaucomatous And Eyes With Primary Open-Angle Glaucoma Milos Todorovic 1, Suncica Sreckovic.

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Year 1 Results Lisa A. Hark, PhD, RD; Michael Waisbourd, MD; Kamran Rahmatnejad, MD;

Risk stratification and calculators

Protocol U Short-Term Evaluation of Combination Dexamethasone + Ranibizumab vs. Ranibizumab Alone for Persistent Central-Involved DME Following Anti-VEGF.

Glaucoma Progression.

Wylegala Edward, Nowinska Anna

Clinical Cases in Glaucoma Treatment

Jordi Loscos Arenas MD, PhD

Anterior Uveitis in a Child

Dra. Olga Garcia-Garcia, Dra. Natalia Diaz-Sanchez, Dr

Mai Pham MD, Sarosh Janjua MD, Jannet Ung MD, Sandra Cremers MD FACS

IOP is not affected by microfibril deficiency.

Predicted vertical cup-to-disc ratio (VCDR) when each of the explanatory variables, intraocular pressure (IOP), central corneal thickness (CCT), body mass.

Presentation transcript:

OHT Treatment criteria First Choice Treatment Dr. Jordi Loscos Arenas Hospital Universitari Germans Trias i Pujol, Barcelona

OHT Treatment criteria IOP Age Race Family History Optic Disc Central Corneal Thickness (CCT) Others: PEX; Myopia; Low ocular pressure; Raynaud Sd; Migraine; Sleep Apnoea Asses each patient individually when deciding whether or not to treat

Family History 56 years old 630 / 622 Sept 2008 IOP 28 mmHg BE Oct 2014 IOP 24/26 mmHg OHT Treatment criteria

No Family History Myopic OSAS 65 years old IOP 20 mmHg BE 513 / 520 OHT Treatment criteria

Family History 44 years old Aprl mmHg BE Jan mmHg BE Oct mmHg 504 /507 OHT Treatment criteria Oct 2014

Family History 63 years old IOP 20 mmHg BE 503 / 494 OHT Treatment criteria

Foto Dra S. Ruiz OHT Treatment criteria

OHT Treatment criteria: Follow up is a "treatment" No Family History 70 years old IOP 24 / 26 mmHg 569 / 572 Taking into account the emotional dimensions

Less influenced by the IOP Importance of baseline visit IOP CCT Optic Nerve photography VF OHT Treatment criteria

Β- Blockers Prostaglandins First Choice Treatment

First Choice Treatment: Prostaglandins

First Choice Treatment: No Family History 79 years old IOP 30 / 28 mmHg 569 / 572 Cataract Phacoemulsification

First Choice Treatment: No Family History 87 years old Bradycardia IOP 28 mmHg BE 560 / 558 No Treatment